P2X7受体通过活性氧依赖机制调控慢性肾脏病中IL-1α介导的炎症
该研究探讨慢性肾脏病(CKD)中IL-1α介导炎症的钙离子和活性氧(ROS)依赖性调控机制。发现CKD单核细胞嘌呤能钙信号改变,抑制P2X7减少IL-1α释放;小鼠中敲除P2X7消除IL-1α释放但增加其表面呈递,损害免疫细胞浸润肾脏却不保护肾功能;P2X7诱导的线粒体ROS是单核细胞释放IL-1α的关键因素,P2X7在调控IL-1α生成中具有双重作用,可能影响CKD治疗结局。
要点
- CKD单核细胞嘌呤能钙信号改变,P2X7和P2X4表达上调。
- 抑制P2X7减少单核细胞IL-1α释放,P2X7诱导的线粒体ROS是必需因素。
- 敲除P2X7消除IL-1α释放但增加其表面呈递,损害免疫细胞浸润肾脏却不保护肾功能。
核心结论
- P2X7通过ROS依赖机制调控IL-1α生物合成,在炎症和心脏重构中具有双重作用,可能影响CKD治疗结局。
研究设计与样本
- 研究纳入人类CKD单核细胞,并采用多种小鼠CKD模型及心肌梗死模型,包括P2X7基因敲除小鼠和嵌合体小鼠。
主要发现
- 人类CKD单核细胞嘌呤能钙信号改变,P2X7和P2X4表达上调;抑制P2X7减少IL-1α释放,抑制P2X4作用较小。
- 小鼠CKD模型中敲除P2X7消除IL-1α释放但增加骨髓来源巨噬细胞表面IL-1α呈递,损害免疫细胞浸润肾脏但不保护肾功能。
- 心肌梗死模型中,损伤野生型和P2X7-/-心脏的免疫细胞浸润相当,与既往肾损伤无关。
- 两种嵌合体小鼠均显示急性炎症减轻,但仅含P2X7-/-免疫细胞的嵌合体对损伤诱导的心脏重构有显著抵抗。
- ROS测量显示P2X7诱导的线粒体ROS是单核细胞释放IL-1α的必需因素。
临床怎么用
- 靶向P2X7调控IL-1α介导炎症时需考虑其双重作用,可能影响CKD患者心脏重构结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Onset, progression and cardiovascular outcome of chronic kidney disease (CKD) are influenced by the concomitant sterile inflammation. The pro-inflammatory cytokine family interleukin (IL)-1 is crucial in CKD with the key alarmin IL-1α playing an additional role as an adhesion molecule that facilitates immune cell tissue infiltration and consequently inflammation. Here, we investigate calcium ion and reactive oxygen species (ROS)-dependent regulation of different aspects of IL-1α-mediated inflammation. We show that human CKD monocytes exhibit altered purinergic calcium ion signatures. Monocyte IL-1α release was reduced when inhibiting P2X7, and to a lesser extent P2X4, two ATP-receptors that were found upregulated compared to monocytes from healthy people. In murine CKD models, deleting P2X7 (P2X7-/-) abolished IL-1α release but increased IL-1α surface presentation by bone marrow derived macrophages and impaired immune cell infiltration of the kidney without protecting kidney function. In contrast, immune cell infiltration into injured wild type and P2X7-/- hearts was comparable in a myocardial infarction model, independent of previous kidney injury. Both the chimeric mouse line harboring P2X7-/- immune cells in wild type recipient mice, and the inversely designed chimeric line showed less acute inflammation. However, only the chimera harboring P2X7-/- immune cells showed a striking resistance against injury-induced cardiac remodeling. Mechanistically, ROS measurements reveal P2X7-induced mitochondrial ROS as an essential factor for IL-1α release by monocytes. Our studies uncover a dual role of P2X7 in regulating IL-1α biogenesis with consequences for inflammation and inflammation-induced deleterious cardiac remodeling that may determine clinical outcomes in CKD therapies.
引用
- Amini M, Frisch J, Jost P, et al. Purinergic receptor P2X7 regulates interleukin-1α mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner. Kidney Int. 2024. PMID: 39571908. doi:10.1016/j.kint.2024.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。